Pearce, Ronald KB

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 414

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease

Pey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M. (2014) · Acta Neuropathologica Communications

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 128

Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies

Moran, L. B., Hickey, L., Michael, G. J., Derkacs, M., Christian, L. M., Kalaitzakis, M. E., Pearce, R. K. B., & Graeber, M. B. (2008) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 69

Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers

Williams, M. R., Chaudhry, R., Perera, S., Pearce, R. K. B., Hirsch, S. R., Ansorge, O., Thom, M., & Maier, M. (2013) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 31